Kilmer Lucas began publishing BioTuesdays in 2009 to fill a clear void of traditional media coverage for small and medium sized healthcare companies.

Delivering compelling investment stories, every Tuesday.

Kilmer Lucas is unique in the investor relations industry in that it publishes its own popular healthcare investor news blog, BioTuesdays. As the name implies, we publish a new Feature article every Tuesday morning. We also post Briefs, based on company press releases, analyst actions and interesting events, throughout the week. So far, BioTuesdays has profiled more than 350 life sciences companies, providing invaluable exposure for innovative technologies and compelling investment stories that may have otherwise gone unnoticed.

BioTuesdays readership can be broken down as follows:

(all percentages approximate)
0
%
individual investors
0
%
institutional investors
0
%
sell-side (bankers, salespeople & analysts)
0
%
big pharma / industry BD
0
%
academia / government
0
%
media / other

This Week's BioTuesdays Feature

BioTuesdays Feature - Novamind